Cargando…

A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]

Detalles Bibliográficos
Autores principales:	Panjaitan, Novaria Sari Dewi, Lestari, Christina Safira Whinie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584780/ https://www.ncbi.nlm.nih.gov/pubmed/36277246 http://dx.doi.org/10.2147/IDR.S393500

Ejemplares similares

A Response to Article “Distribution of Mcr-1 Harboring Hypervirulent Klebsiella Pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Thoughtful Response on “MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains
por: Ito, Ryota, et al.
Publicado: (2022)

Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018
por: Sunarno, Sunarno, et al.
Publicado: (2023)

Critical Response to Article “Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis” [Letter]
por: Rinendyaputri, Ratih, et al.
Publicado: (2023)

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
por: Lestari, Christina Safira Whinie, et al.
Publicado: (2023)

A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]
por: Panjaitan, Novaria Sari Dewi
Publicado: (2022)

Thoughtful Discussion on Article “Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo” [Letter]
por: Hidayat, Syarif, et al.
Publicado: (2023)

Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Letter]
por: Maha, Masri Sembiring, et al.
Publicado: (2023)

A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016)

Response on Article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

658. Evaluation of Effectiveness of Cefmetazole vs Meropenem for Invasive Urinary Tract Infections Caused by ESBL-Producing Escherichia coli: A Prospective Multicenter Observational Study
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Questions Regarding Variants in ADIPOQ in Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
por: Lienggonegoro, Lisa Andriani, et al.
Publicado: (2023)

A Response to Article “Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis” [Letter]
por: Mariya, Sela S, et al.
Publicado: (2023)

The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Goto, Akihiko, et al.
Publicado: (2021)

Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Kang, Cheol-In
Publicado: (2021)

Genotyping of ESBL Producing Uropathogenic Escherichia coli in West of Iran
por: Mohajeri, Parviz, et al.
Publicado: (2014)

Characterization of qnrB-carrying plasmids from ESBL- and non-ESBL-producing Escherichia coli
por: Juraschek, Katharina, et al.
Publicado: (2022)

Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden
por: Helldal, Lisa, et al.
Publicado: (2017)

Clonal Relationship and Resistance Profiles Among ESBL-Producing Escherichia coli
por: Dolatyar Dehkharghani, Alireza, et al.
Publicado: (2021)

Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany
por: Perestrelo, Sara, et al.
Publicado: (2022)

Genome Analysis of ESBL-Producing Escherichia coli Isolated from Pigs
por: Founou, Luria Leslie, et al.
Publicado: (2022)

Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole
por: Horie, Akiyoshi, et al.
Publicado: (2019)

Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains
por: Celebi, Demet, et al.
Publicado: (2023)

Antimicrobial-resistant and ESBL-producing Escherichia coli in different ecological niches in Bangladesh
por: Rashid, Mahmudur, et al.
Publicado: (2015)

Comparative Exposure Assessment of ESBL-Producing Escherichia coli through Meat Consumption
por: Evers, Eric G., et al.
Publicado: (2017)

Occurrence of multidrug-resistant and ESBL-producing atypical enteropathogenic Escherichia coli in China
por: Xu, Yanmei, et al.
Publicado: (2018)

Detection and Characterization of ESBL-Producing Escherichia coli From Humans and Poultry in Ghana
por: Falgenhauer, Linda, et al.
Publicado: (2019)

A Descriptive Analysis of Urinary ESBL-Producing-Escherichia coli in Cerdanya Hospital
por: Gaviria, Lorena Patrícia, et al.
Publicado: (2022)

Molecular characteristics of ESBL-producing Escherichia coli isolated from chickens with colibacillosis
por: Yoon, Sunghyun, et al.
Publicado: (2022)

Decreased detection of ESBL- or pAmpC-producing Escherichia coli in broiler breeders imported into Sweden
por: Nilsson, Oskar, et al.
Publicado: (2020)

Characterization of Multidrug Resistant ESBL-Producing Escherichia coli Isolates from Hospitals in Malaysia
por: Lim, King-Ting, et al.
Publicado: (2009)

Hygiene quality and presence of ESBL-producing Escherichia coli in raw food diets for dogs
por: Nilsson, Oskar
Publicado: (2015)

Dynamics of faecal shedding of ESBL- or AmpC-producing Escherichia coli on dairy farms
por: Hordijk, Joost, et al.
Publicado: (2019)

Correction: Comparative Exposure Assessment of ESBL-Producing Escherichia coli through Meat Consumption
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nq74htmuctqj4eq1180sec0j93